H. Torii, Takeda Kenkyushoho, 40, No. 3/4, 180-191 (1982). |
Pals et al., Circulation Research, 29, 673 (1971). |
Streeten and Anderson, Handbook of Hypertension, vol. 5, Clinical Pharmacology of Antihypertensive Drugs, A. E. Doyle (Editor), Elsevier Science Publishers B.V., p. 246 (1984). |
Satoh, et al., Cir. Res. 36/37 & Suppl. I): I-89, 1975. |
Blasingham et al., Am. J. Physiol., 239:F360, 1980. |
Wong et al., Pharmacol. Exp. Ther., 215:104, 1980. |
Dunn, Hospital Practice, 19:99, 1984. |
Dzau et al., N. Eng. J. Med., 310:347, 1984. |
Lindgren et al., Eur. J. Pharmacol., 135:383, 1987. |
Zatz et al., Kidney International, vol. 31, Suppl. 20, pp. S-123-129 (1987). |
Schmidt et al., J. Cardiovascular Pharmacology, vol. 8, pp. S100-105 (1986). |
Wong et al., Abstract No. 30, Hypertension, p. 340, vol. 12, No. 3, Sep. 1988. |
High Blood Pressure Council Mtg., San Francisco, Calif., Sep. 28-Oct. 1, 1988, "X-6803 Methyl 2-N-Butyl-1-(4-(2-Carboxybenzamido)Benzyl-4-Chloroimidazole-5-Acetate, Sodium Salt): A Novel Nonpeptide Angiotension II Receptor Antagonist". |
Chiu et al., Abstract No. 118.11, The Pharmacologist, vol. 30, p. A165, 1988, for ASPET mtg., Montreal Canada, Oct. 9-13, 1988: "Nonpeptide Angiotensin II (AII) Receptor Antogonists: Structure Function Studies". |
Wong et al., "Nonpeptide Angiotensin II Receptor Antognists. I. Pharmacological Characterization of 2-n-Butyl-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307)", J. Pharmacology and Experimental Therapeutics, vol. 247, No. 1, pp. 1-7. |
Chiu et al., "Non-peptide angiotensin II Receptor antognists. II. Pharmacology of S-8308", European Journal of Pharmacology, vol. 157, pp. 13-21 (1988). |